Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.64 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.64 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | PPARD | Q03181 | 1/20 | 0.47 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.47 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5080592 | 1.00 | GPR84 (0.64) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL10782775 | 1.00 | GPR84 (0.64) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL3699841 | 1.00 | GPR84 (0.64) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL8717281 | 1.00 | GPR84 (0.64) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL943706 | 0.98 | GPR84 (0.61) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL303329 | 0.92 | GPR84 (0.52) | GPR84FFAR1FFAR4MAPT | |
| SCHEMBL51445 | 0.83 | CHRM1 (0.42) | GPR84FFAR1FFAR4 | |
| SCHEMBL17760826 | 0.82 | GPR84 (0.57) | GPR84FFAR1FFAR4MAPT | |
| SCHEMBL7118127 | 0.82 | GPR84 (0.47) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL7049211 | 0.82 | GPR84 (0.41) | GPR84FFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120122694-A1 | VERBESSERTE MICROKAPSELN UND IHRE HERSTELLUNG IMPROVED MICROCAPSULES, AND THEIR PRODUCTION THEREOF | Follmann & Co. Gesellschaft fur Chemie-Werkstoffe und Verfahrenstechnik mbH & Co. KG (DE) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122694-A1 | VERBESSERTE MICROKAPSELN UND IHRE HERSTELLUNG IMPROVED MICROCAPSULES, AND THEIR PRODUCTION THEREOF | VIM, ADH5, DCXR | GPR84 3929/4885FFAR1 2933/4885FFAR4 3034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.